Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca

Probiodrug Funds Brigham and Women’s Research into Antibody Targeting Pyroglutamated Abeta for Treatment of Alzheimer’s Disease
Probiodrug and VU University Medical Center in Amsterdam to Collaborate on the Development of Alzheimer’s Disease Biomarker Assays